speb/financial-data huggingface dataset:
CGEN balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -6230000.00
CGEN balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 533213000.00
CGEN income_statement (annual, 2022-12-31) — Basic Average Shares: 86555628.00
CGEN income_statement (annual, 2022-12-31) — Basic EPS: -0.39
CGEN cash_flow (annual, 2022-12-31) — Beginning Cash Position: 8514000.00
CGEN cash_flow (annual, 2022-12-31) — Capital Expenditure: -487000.00
CGEN balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 1925000.00
CGEN balance_sheet (annual, 2022-12-31) — Capital Stock: 240000.00
CGEN balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 11059000.00
CGEN balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 83346000.00
CGEN cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 353000.00
CGEN cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: 37060000.00
CGEN cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -34113000.00
CGEN cash_flow (annual, 2022-12-31) — Change In Account Payable: -1601000.00
CGEN cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 658000.00
CGEN cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -1062000.00
CGEN cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -6019000.00
CGEN cash_flow (annual, 2022-12-31) — Change In Payable: -1601000.00
CGEN cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -1601000.00
CGEN cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 12000.00
CGEN cash_flow (annual, 2022-12-31) — Change In Receivables: 2459000.00
CGEN cash_flow (annual, 2022-12-31) — Change In Working Capital: -5553000.00
CGEN cash_flow (annual, 2022-12-31) — Changes In Account Receivables: 0.00
CGEN cash_flow (annual, 2022-12-31) — Changes In Cash: 3300000.00
CGEN balance_sheet (annual, 2022-12-31) — Common Stock: 240000.00
CGEN balance_sheet (annual, 2022-12-31) — Common Stock Equity: 77680000.00
CGEN cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
CGEN income_statement (annual, 2022-12-31) — Cost Of Revenue: 975000.00
CGEN balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 6396000.00
CGEN balance_sheet (annual, 2022-12-31) — Current Assets: 86125000.00
CGEN balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 613000.00
CGEN balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 613000.00
CGEN balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 325000.00
CGEN balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 0.00
CGEN balance_sheet (annual, 2022-12-31) — Current Liabilities: 11919000.00
CGEN balance_sheet (annual, 2022-12-31) — Defined Pension Benefit: 2794000.00
CGEN cash_flow (annual, 2022-12-31) — Depreciation: 482000.00
CGEN cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 482000.00
CGEN cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 482000.00
CGEN income_statement (annual, 2022-12-31) — Diluted Average Shares: 86555628.00
CGEN income_statement (annual, 2022-12-31) — Diluted EPS: -0.39
CGEN income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -33694000.00
CGEN income_statement (annual, 2022-12-31) — EBIT: -35374000.00
CGEN income_statement (annual, 2022-12-31) — EBITDA: -34892000.00
CGEN cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -393000.00
CGEN balance_sheet (annual, 2022-12-31) — Employee Benefits: 3265000.00
CGEN cash_flow (annual, 2022-12-31) — End Cash Position: 11421000.00
CGEN cash_flow (annual, 2022-12-31) — Financing Cash Flow: 353000.00
CGEN cash_flow (annual, 2022-12-31) — Free Cash Flow: -34600000.00
CGEN cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 12000.00
CGEN income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: -12000.00
CGEN income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 340000.00
CGEN balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 0.00
CGEN income_statement (annual, 2022-12-31) — General And Administrative Expense: 10319000.00
CGEN balance_sheet (annual, 2022-12-31) — Gross PPE: 9588000.00
CGEN income_statement (annual, 2022-12-31) — Gross Profit: 6525000.00
CGEN income_statement (annual, 2022-12-31) — Interest Expense: 27000.00
CGEN income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 27000.00
CGEN income_statement (annual, 2022-12-31) — Interest Income: 1437000.00
CGEN income_statement (annual, 2022-12-31) — Interest Income Non Operating: 1437000.00
CGEN cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 852000.00
CGEN balance_sheet (annual, 2022-12-31) — Invested Capital: 77680000.00
CGEN cash_flow (annual, 2022-12-31) — Investing Cash Flow: 37060000.00
CGEN cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
CGEN balance_sheet (annual, 2022-12-31) — Leases: 2314000.00
CGEN balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 1312000.00
CGEN balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 1312000.00
CGEN balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 5448000.00
CGEN cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
CGEN cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: 393000.00
CGEN income_statement (annual, 2022-12-31) — Net Income: -33694000.00
CGEN income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -33694000.00
CGEN income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -33694000.00
CGEN income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -33694000.00
CGEN income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -33694000.00
CGEN cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -33694000.00
CGEN income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -33694000.00
CGEN income_statement (annual, 2022-12-31) — Net Interest Income: 1410000.00
CGEN cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 37545000.00
CGEN income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 1410000.00
CGEN balance_sheet (annual, 2022-12-31) — Net PPE: 3358000.00
CGEN cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -485000.00
CGEN balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 77680000.00
CGEN balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 0.00
CGEN balance_sheet (annual, 2022-12-31) — Non Current Deferred Revenue: 0.00
CGEN balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 3265000.00
CGEN balance_sheet (annual, 2022-12-31) — Non Current Prepaid Assets: 1899000.00
CGEN income_statement (annual, 2022-12-31) — Normalized EBITDA: -35220000.00
CGEN income_statement (annual, 2022-12-31) — Normalized Income: -33946560.00
CGEN cash_flow (annual, 2022-12-31) — Operating Cash Flow: -34113000.00
CGEN cash_flow (annual, 2022-12-31) — Operating Gains Losses: 324000.00
CGEN income_statement (annual, 2022-12-31) — Operating Income: -35374000.00
CGEN income_statement (annual, 2022-12-31) — Operating Revenue: 7500000.00
CGEN balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 86624643.00
CGEN income_statement (annual, 2022-12-31) — Other Gand A: 10319000.00
CGEN income_statement (annual, 2022-12-31) — Other Income Expense: 328000.00
CGEN balance_sheet (annual, 2022-12-31) — Other Properties: 1826000.00
CGEN balance_sheet (annual, 2022-12-31) — Other Receivables: 317000.00
CGEN balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 72287000.00
CGEN balance_sheet (annual, 2022-12-31) — Payables: 1773000.00
CGEN balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 8169000.00
CGEN cash_flow (annual, 2022-12-31) — Pension And Employee Benefit Expense: -81000.00
CGEN balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 2812000.00
CGEN balance_sheet (annual, 2022-12-31) — Prepaid Assets: 2100000.00
CGEN income_statement (annual, 2022-12-31) — Pretax Income: -33636000.00
CGEN cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 353000.00
CGEN balance_sheet (annual, 2022-12-31) — Properties: 0.00
CGEN cash_flow (annual, 2022-12-31) — Purchase Of Investment: -76900000.00
CGEN cash_flow (annual, 2022-12-31) — Purchase Of PPE: -487000.00
CGEN balance_sheet (annual, 2022-12-31) — Receivables: 317000.00
CGEN income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 975000.00
CGEN income_statement (annual, 2022-12-31) — Reconciled Depreciation: 482000.00
CGEN income_statement (annual, 2022-12-31) — Research And Development: 30648000.00
CGEN balance_sheet (annual, 2022-12-31) — Restricted Cash: 362000.00
CGEN balance_sheet (annual, 2022-12-31) — Retained Earnings: -455773000.00
CGEN cash_flow (annual, 2022-12-31) — Sale Of Investment: 114445000.00
CGEN cash_flow (annual, 2022-12-31) — Sale Of PPE: 2000.00
CGEN income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 932000.00
CGEN income_statement (annual, 2022-12-31) — Selling General And Administration: 11251000.00
CGEN balance_sheet (annual, 2022-12-31) — Share Issued: 86624643.00
CGEN income_statement (annual, 2022-12-31) — Special Income Charges: -12000.00
CGEN cash_flow (annual, 2022-12-31) — Stock Based Compensation: 4328000.00
CGEN balance_sheet (annual, 2022-12-31) — Stockholders Equity: 77680000.00
CGEN balance_sheet (annual, 2022-12-31) — Tangible Book Value: 77680000.00
CGEN income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 75440.00
CGEN income_statement (annual, 2022-12-31) — Tax Provision: 58000.00
CGEN income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.23
CGEN balance_sheet (annual, 2022-12-31) — Total Assets: 94176000.00
CGEN balance_sheet (annual, 2022-12-31) — Total Capitalization: 77680000.00
CGEN balance_sheet (annual, 2022-12-31) — Total Debt: 1925000.00
CGEN balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 77680000.00
CGEN income_statement (annual, 2022-12-31) — Total Expenses: 42874000.00
CGEN balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 16496000.00
CGEN balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 8051000.00
CGEN balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 4577000.00
CGEN income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -35374000.00
CGEN income_statement (annual, 2022-12-31) — Total Other Finance Cost: 27000.00
CGEN income_statement (annual, 2022-12-31) — Total Unusual Items: 328000.00
CGEN income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 328000.00
CGEN balance_sheet (annual, 2022-12-31) — Working Capital: 74206000.00
CGEN income_statement (annual, 2023-12-31) — +Operating Expense: 44447000.00
CGEN income_statement (annual, 2023-12-31) — +Total Revenue: 33459000.00
CGEN balance_sheet (annual, 2023-12-31) — Accounts Payable: 3502000.00
CGEN balance_sheet (annual, 2023-12-31) — Accounts Receivable: 61000000.00
CGEN balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -5356000.00
CGEN balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 539837000.00
CGEN income_statement (annual, 2023-12-31) — Basic Average Shares: 87633298.00
CGEN income_statement (annual, 2023-12-31) — Basic EPS: -0.21
CGEN cash_flow (annual, 2023-12-31) — Beginning Cash Position: 11421000.00
CGEN cash_flow (annual, 2023-12-31) — Capital Expenditure: -172000.00